Quick Facts
FONT-SIZE Plus   Neg
Share SHARE
mail  E-MAIL

PROLOR Biotech Plans Stock Offering

RELATED NEWS
Trade PBTH now with 
5/10/2012 7:13 PM ET

PROLOR Biotech, Inc. (PBTH: Quote) said Thursday that it plans to offer and sell shares of its common stock in an underwritten public offering.

The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

PROLOR said it plans to use the net proceeds from the offering for general corporate purposes, which may include research and development expenses, including expenses related to clinical trials, capital expenditures, working capital, and general and administrative expenses. PROLOR may also use a portion of the net proceeds to acquire or invest in complementary businesses, products and technologies.

Click here to receive FREE breaking news email alerts for PROLOR Biotech, Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After moving sharply lower at the open, stocks have regained some ground over the course of morning trading on Thursday. The major averages have climbed well off their worst levels of the day but remain stuck in the red. In another upbeat sign for the U.S. housing market, the Commerce Department released a report on Thursday showing that new home sales came in well above economist estimates in the month of April. The report showed that new home sales climbed 2.3 percent to a seasonally adjusted annual rate of 454,000 in April from the revised March rate of 444,000. Consumer sentiment in the euro area increased for the sixth consecutive month in May to its strongest level since the middle of last year, preliminary data from the European Commission showed Thursday. The DG ECFIN flash estimate of the consumer confidence indicator for Eurozone came in at -21.9,...
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.